Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by princeofcuton Apr 30, 2015 3:16pm
111 Views
Post# 23682000

RE:RE:RE:RE:RE:RE:Didn't the little boy who cried wolf...

RE:RE:RE:RE:RE:RE:Didn't the little boy who cried wolf...jkj, here is a thought; it was a joke, it is a joke, and it will be a joke...IMO any BP would look at the Zenith thingy and say "huh you got to be kidding me" get rid of the Zenith ORRI (ie give away to insiders) and then we can talk seriously...IMO Zenith was Alice in Wonderland dealing to enable Crestor or Lipitor folks to buy only what they wanted and so now that we are in the wonderous world of diabetes...well..maybe Zenith gets diluted back into RVX or some other recombo...it was a joke, glad i got the freebies but a joke is a joke and how do we know it is a joke...well how many trials have they started???? and who created that joke???
Bullboard Posts